Common TitlePOLARIS-4
Official Title Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection
Phase Phase III
ClinicalTrials.gov NCT02639247
Treatments
Sofosbuvir-Velpatasvir-Voxilaprevir

Sofosbuvir-Velpatasvir-Voxilaprevir
Tradename:VoseviOther Names:SOF-VEL-VOXClass:FDA-ApprovedFunding
IndustryGilead Sciences